Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Systemic Lupus Erythematosus

NCT03296995 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03296995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Systemic Lupus Erythematosus
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2017
Completion date
October 1, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, diabetic blood glucose monitoring, systemic lupus erythematosus